Lack of flow mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice

Lupus

Volumn 15, Issue 6, 2006, Pages 326-334

  Bagi, Z ^a   Hamar, P ^b   Kardos, M ^b   Koller, Akos ^b,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin II; Endothelium; Flow mediated dilation; Isolated arteriole; Systemic lupus erythematosus

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN II; BRADYKININ; NITROPRUSSIDE SODIUM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD FLOW; CONTROLLED STUDY; EXPERIMENTAL MODEL; MICROCIRCULATION; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN II; ANIMALS; ANTIBODIES, ANTINUCLEAR; ARTERIOLES; BLOOD PRESSURE; BRADYKININ; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HEMORHEOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; MUSCLE, SKELETAL; NITROPRUSSIDE; SEROTONIN; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 33745824615     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2297oa     Document Type: Article

References (33)

1. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 2003; 48: 3159-3167.
2. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
3. Doria A, Shoenfeld Y, Wu R et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 1071-1077.
4. Ansari A, Larson PH, Bates HD. Vascular manifestations of systemic lupus erythematosus. Angiology 1986; 37: 423-432.
5. Urowitz M, Gladman D, Bruce I. Atherosclerosis and systemic lupus erythematosus. Curr Rheumatol Rep 2000; 2: 19-23.
6. Urowitz MB, Gladman DD. Accelerated atheroma in lupus: background. Lupus 2000; 9: 161-165.
7. Bruce IN, Gladman DD, Ibanez D, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. J Rheumatol 2003; 30: 288-291.
8. Lin CC, Ding HJ, Chen YW, Wang JJ, Ho ST, Kao A. High prevalence of asymptomatically poor muscle perfusion of lower extremities measured in systemic lupus erythematosus patients with abnormal myocardial perfusion. Rheumatol Int 2004; 24: 227-229.
9. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999; 79: 387-423.
10. Koller A, Kaley G. Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. Am J Physiol 1991; 260: 862-868.
11. Koller A, Bagi Z. On the role of mechanosensitive mechanisms eliciting reactive hyperemia. Am J Physiol Heart Circ Physiol 2002; 283: 2250-2259.
12. Koller A. Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation 2002; 9: 277-294.
13. Smathers PA, Santoro TJ, Chused TM, Reeves JP, Steinberg AD. Studies of lymphoproliferation in MRL-lpr/lpr mice. J Immunol 1984; 133: 1955-1961.
14. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990; 33: 634-643.
15. Bagi Z, Hamar P, Antus B, Rosivall L, Koller A. Chronic renal failure leads to reduced flow-dependent dilation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Press Res 2003; 26: 19-26.
16. Berden JH, Hang L, McConahey PJ, Dixon FJ. Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol 1983; 130: 1699-1705.
17. Frampton G, Hobby P, Morgan A, Staines NA, Cameron JS. A role for DNA in anti-DNA antibodies binding to endothelial cells. J Autoimmun 1991; 4: 463-478.
18. Moyer CF, Strandberg JD, Reinisch CL. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am J Pathol 1987; 127: 229-242.
19. Moyer CF, Reinisch CL. Vascutitis in MRL/1 pr mice: model of cell-mediated autoimmunity. Toxicol Pathol 1989; 17: 122-128.
20. El Magadmi M, Bodill H, Ahmad Y et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399-404.
21. Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 292-297.
22. Bagi Z, Frangos JA, Yeh JC, White CR, Kaley G, Koller A. PECAM-1 mediates NO-dependent dilation of arterioles to high temporal gradients of shear stress. Arterioscler Thromb Vasc Biol 2005; 25: 1590-1595.
23. Cheng C, van Haperen R, de Waard M et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 2005; 106: 3691-3698.
24. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension 1986; 8: 553-559.
25. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl 1990; 8: 225-232.
26. Perez DL, De Wit C, Cohen CD et al. Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice. J Pharmacol Exp Ther 2003; 307: 275-281.
27. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002; 4: 899-914.
28. Bae SC, Kim SJ, Sung MK. Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus. Rheumatol Int 2002; 22: 238-243.
29. Kurien BT, Scofield RH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003; 73: 1655-1666.
30. Csiszar A, Ungvari Z, Edwards JG et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002; 90: 1159-1166.
31. Ungvari Z, Csiszar A, Edwards JG et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003; 23: 418-424.
32. Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G. Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. Faseb J 2003; 17: 1183-1185.
33. Asanuma Y, Oeser A, Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. New Eng J Med 2003; 349: 2407-2415.